Largest Healthcare-Focused IR Firm -- Westwicke Partners --

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Largest Healthcare-Focused IR Firm -- Westwicke Partners -- Announces Growth, Adds Key Personnel

BALTIMORE, Md., May 12, 2014 (GLOBE NEWSWIRE) -- via PRWEB - The largest healthcare-focused investor relations (IR) firm in the country, Westwicke Partners , is pleased to announce that three senior-level advisors -- Ana Petrovic, Jamar Ismail, and Peter Vozzo -- have been added to the team this year to serve the rising demand among healthcare companies to develop and execute independent capital markets and IR strategies.

Like Westwicke's other team members, who have more than 200 years of combined Wall Street experience, Petrovic, Ismail, and Vozzo bring to their new positions substantial experience from both Wall Street and the healthcare industry. Vozzo spent two decades as a sell-side analyst and IR professional at various healthcare companies in Maryland; Ismail worked for many years as a buy-side analyst, equity researcher, and member of prominent IR medical technology teams; and Petrovic spent seven years as a sell-side analyst, following a career as a biologist at the National Institutes of Health.

Westwicke Partners ' deep Wall Street experience is a defining characteristic of the company's approach to IR, providing team members with "real-life" views of the challenges senior management teams face building and maintaining relationships with shareholders and investors. The professionals work under a structure of dedicated teams focused on life sciences, healthcare services/healthcare information technology, and medical technology/diagnostics.

"Our unique Wall Street experience and team set up allow us to leverage existing knowledge and relationships with the leading buy-side institutions, sell-side analysts, and investment bankers -- ultimately giving clients the highest-value of service," explained Mark Klausner, a managing partner at Westwicke who spent 17 years in senior-level positions in investment banking and equity capital markets.

"The careers of these new team members reflect core attributes that drive the success of our company and our clients, particularly a strong commitment to client service and a dedication to teamwork," said Bob East, another managing partner with close to 20 years of prior experience working on Wall Street in institutional sales. "We congratulate our new teammates on their accomplishments to date, and we know they will continue to thrive in their new roles as they help our clients achieve their business goals and contribute to the success and growth of our company."

About Westwicke Partners

Westwicke Partners provides customized investor relations programs and independent capital markets advice to public and private healthcare companies. For more information, please contact Tom McDonald at 443-213-0508 or tom.mcdonald@westwicke.com, or visit http://www.westwickepartners.com .

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/05/prweb11839201.htm

KCM PR Karen McGagh +1 (443) 632-4217

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 18

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
Skilled Nursing: The Backbone of Comprehensive Care

Updated Category News Views 17

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Continue Reading
Nauticus Schedules 2026 Q3 Earnings Call; Key Insights Await

Updated Category News Views 100

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 266

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Baidu Faces Securities Suit Deadline This Week

Updated Category News Views 74

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

Continue Reading
FIS Under Investigation: Legal Woes Hit Shareholders

Updated Category News Views 55

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 124

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
Frasle Mobility's Resilience Despite Market Woes in 3Q26

Updated Category News Views 125

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Continue Reading
MY DR NOW Challenges 9-to-5 with New Clinics

Updated Category News Views 12

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Continue Reading

Top 5 Most Recently Viewed Articles

Immunocore Unveils Promising Data for Brenetafusp in Ovarian Cancer

Updated Category News Views 129

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Continue Reading
Santhera and Ikris Pharma Join Forces for AGAMREE® in India

Updated Category News Views 216

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Continue Reading
Orchid Island Capital Highlights August Dividend and Portfolio Insights

Updated Category News Views 183

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

Continue Reading
Mercari Japan App Debuts in U.S.: A Shopping Shift

Updated Category News Views 15

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Continue Reading
Franklin Access Receives Financing for Groundbreaking Sigbeat Venture

Updated Category News Views 195

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...

Continue Reading